Skip to content
Search

Latest Stories

LloydsPharmacy Online Doctor joins hands with Preventx to boost STI testing service

LloydsPharmacy Online Doctor joins hands with Preventx to boost STI testing service

The test samples sent by patients are processed at Preventx laboratory and results are made available within 72 hours 

LloydsPharmacy Online Doctor has entered into a partnership with the UK’s leading diagnostic provider, Preventx, to boost its sexually transmitted infection (STI) testing service, which include tests for chlamydia, gonorrhoea, syphilis and HIV.


The at-home test kits are made available online at online doctor’s website, and tests range from a finger-prick blood test to a PCR test, depending on the infection.

Along with the kits, customers would be provided with expert information to guide them through the self-testing process.

The samples sent by the patients will be processed by Preventx at their bespoke laboratory, and results would be available to patients within 72 hours via their patient record.

Andy Sloman, CEO LloydsPharmacy Online Doctor, said their partnership with Preventx will empower their customers “to take control of their health, keeping themselves and their partners safe.”

Cautioning that STIs are on the rise and there was 24 per cent increase in new diagnoses in 2022, Preventx CEO Ruth Poole stressed the importance of regular testing in people who are sexually active.

Commenting on the new partnership, she said: “By combining our expertise and the intelligent use of tech to make testing more accessible, we believe our partnership will enable more people to proactively manage their sexual health and prevent onward transmission of infections.”

According to the data published by the UK Health Security Agency, there were 392,453 diagnoses of new sexually transmitted infections (STIs) in England in 2022, an increase of 23.8 per cent compared to 2021 (317,022).

Statistics showed more than 24 per cent increase in chlamydia diagnoses, from 160,279 diagnoses in 2021 to 199,233 in 2022.

Both gonorrhoea and syphilis were on the rise, with the number returning to the high levels reported in 2019 prior to the coronavirus COVID-19 pandemic.

Gonorrhoea diagnoses increased to 82,592 diagnoses in 2022 from 54,961 the previous year, and infectious syphilis diagnoses went up to 8,692 in 2022 from 7,543 in 2021.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less